129 related articles for article (PubMed ID: 11554060)
1. [Progress in study for mechanism of gastric mucosal injury].
Yoshida N
Nihon Rinsho; 2001 Sep; 59(9):1829-36. PubMed ID: 11554060
[TBL] [Abstract][Full Text] [Related]
2. Eradication therapy of Helicobacter pylori directly induces apoptosis in inflammation-related immunocytes in the gastric mucosa--possible mechanism for cure of peptic ulcer disease and MALT lymphoma with a low-grade malignancy.
Ohara T; Kanoh Y; Higuchi K; Arakawa T; Morisita T
Hepatogastroenterology; 2003; 50(51):607-9. PubMed ID: 12828043
[TBL] [Abstract][Full Text] [Related]
3. Effect of Helicobacter pylori eradication on anti-thrombotic dose aspirin-induced gastroduodenal mucosal injury.
Giral A; Ozdogan O; Celikel CA; Tozun N; Ulusoy NB; Kalayci C
J Gastroenterol Hepatol; 2004 Jul; 19(7):773-7. PubMed ID: 15209624
[TBL] [Abstract][Full Text] [Related]
4. Interaction of nonsteroidal anti-inflammatory drugs (NSAID) with Helicobacter pylori in the stomach of humans and experimental animals.
Brzozowski T; Konturek PC; Sliwowski Z; Kwiecień S; Drozdowicz D; Pawlik M; Mach K; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2006 Sep; 57 Suppl 3():67-79. PubMed ID: 17033106
[TBL] [Abstract][Full Text] [Related]
5. Interaction of Helicobacter pylori infection and nonsteroidal anti-inflammatory drugs in gastric and duodenal ulcers.
Venerito M; Malfertheiner P
Helicobacter; 2010 Aug; 15(4):239-50. PubMed ID: 20633184
[TBL] [Abstract][Full Text] [Related]
6. Reactive oxygen metabolites and upper gastrointestinal diseases.
Kountouras J; Chatzopoulos D; Zavos C
Hepatogastroenterology; 2001; 48(39):743-51. PubMed ID: 11462918
[TBL] [Abstract][Full Text] [Related]
7. Physiological mediators in nonsteroidal anti-inflammatory drugs (NSAIDs)-induced impairment of gastric mucosal defense and adaptation. Focus on nitric oxide and lipoxins.
Brzozowski T; Konturek PC; Pajdo R; Ptak-Belowska A; Kwiecien S; Pawlik M; Drozdowicz D; Sliwowski Z; Brzozowski B; Konturek SJ; Pawlik WW
J Physiol Pharmacol; 2008 Aug; 59 Suppl 2():89-102. PubMed ID: 18812631
[TBL] [Abstract][Full Text] [Related]
8. [The assessment of nitric oxide metabolites in gastric juice in Helicobacter pylori infected subjects in compliance with grade of inflammatory lesions in gastric mucosa].
Walecka-Kapica E; Knopik-Dabrowicz A; Klupińska G; Chojnacki J
Pol Merkur Lekarski; 2008 Feb; 24(140):95-100. PubMed ID: 18634262
[TBL] [Abstract][Full Text] [Related]
9. Effect of non-steroidal anti-inflammatory drugs on gastric and duodenal prostaglandin concentrations in patients with Helicobacter pylori infection.
Tseng GY; Lin HJ; Lin HY; Perng CL; Lee FY; Lo WC; Tsay SH; Li AS; Chang FY; Lee SD
Hepatogastroenterology; 1999; 46(26):1000-4. PubMed ID: 10370655
[TBL] [Abstract][Full Text] [Related]
10. Up-regulation of endothelin-1 in gastric mucosal inflammatory responses to Helicobacter pylori Lipopolysaccharide: effect of omeprazole and sucralfate.
Slomiany BL; Piotrowski J; Slomiany A
J Physiol Pharmacol; 2000 Jun; 51(2):179-92. PubMed ID: 10898092
[TBL] [Abstract][Full Text] [Related]
11. Non-steroidal anti-inflammatory drugs associated with gastroduodenal injury and Helicobacter pylori.
Mizokami Y; Tamura K; Fukuda Y; Yamamoto I; Shimoyama T
Eur J Gastroenterol Hepatol; 1994 Dec; 6 Suppl 1():S109-12. PubMed ID: 7735925
[TBL] [Abstract][Full Text] [Related]
12. Helicobacter pylori eradication in patients on long-term treatment with NSAIDs reduces the severity of gastritis: a randomized controlled trial.
De Leest HT; Steen KS; Bloemena E; Lems WF; Kuipers EJ; Van de Laar MA; Bijlsma JW; Janssen M; Houben HH; Kostense PJ; Boers M; Dijkmans BA
J Clin Gastroenterol; 2009 Feb; 43(2):140-6. PubMed ID: 18797408
[TBL] [Abstract][Full Text] [Related]
13. Influence of Helicobacter pylori eradication therapy on the occurrence of gastrointestinal events in patients treated with conventional nonsteroidal antiinflammatory drugs combined with omeprazole.
Bannwarth B; Dorval E; Caekaert A; Barthelemy P
J Rheumatol; 2002 Sep; 29(9):1975-80. PubMed ID: 12233895
[TBL] [Abstract][Full Text] [Related]
14. Does Helicobacter pylori Exacerbate Gastric Mucosal Injury in Users of Nonsteroidal Anti-Inflammatory Drugs? A Multicenter, Retrospective, Case-Control Study.
Kono Y; Okada H; Takenaka R; Miura K; Kanzaki H; Hori K; Kita M; Tsuzuki T; Kawano S; Kawahara Y; Yamamoto K
Gut Liver; 2016 Jan; 10(1):69-75. PubMed ID: 26087789
[TBL] [Abstract][Full Text] [Related]
15. [Effect of NSAIDs on gastric mucosal damage induced by H. pylori infection].
Iwakiri R; Fujimoto K
Nihon Rinsho; 2002 Feb; 60 Suppl 2():222-6. PubMed ID: 11979782
[No Abstract] [Full Text] [Related]
16. Usefulness of proton pump inhibitor (PPI) maintenance therapy for patients with H. pylori-negative recurrent peptic ulcer after eradication therapy for H. pylori: pathophysiological characteristics of H. pylori-negative recurrent ulcer scars and beyond acid suppression by PPI.
Ohara T; Morishita T; Suzuki H; Masaoka T; Ishii H
Hepatogastroenterology; 2004; 51(56):338-42. PubMed ID: 15086153
[TBL] [Abstract][Full Text] [Related]
17. Up-regulation of gastric mucosal inflammatory responses to Helicobacter pylori lipopolysaccharide by aspirin but not indomethacin.
Slomiany BL; Piotrowski J; Slomiany A
J Endotoxin Res; 2001; 7(3):203-9. PubMed ID: 11581571
[TBL] [Abstract][Full Text] [Related]
18. Comparison of nitric oxide-releasing NSAID and vitamin C with classic NSAID in healing of chronic gastric ulcers; involvement of reactive oxygen species.
Brzozowski T; Kwiecień S; Konturek PC; Konturek SJ; Mitis-Musiol M; Duda A; Bielański W; Hahn EG
Med Sci Monit; 2001; 7(4):592-9. PubMed ID: 11433182
[TBL] [Abstract][Full Text] [Related]
19. [Intractable ulcer after the eradication of Helicobacter pylori].
Taguchi Y; Imoto I
Nihon Rinsho; 2002 Feb; 60 Suppl 2():483-7. PubMed ID: 11979832
[No Abstract] [Full Text] [Related]
20. The interaction of H. pylori infection and NSAIDs in cyclooxygenase-2 mRNA expression in gastric antral, corpus mucosa, and gastric ulcer.
Wu CY; Wu MS; Chen CJ; Li MC; Lin JT; Chen GH
J Clin Gastroenterol; 2005 Jan; 39(1):50-5. PubMed ID: 15599211
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
